We are live on ! Find out more
ACET icon

Adicet Bio
ACET

58 hedge funds and large institutions have $156M invested in Adicet Bio in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.26% less ownership

Funds ownership: 4.17% → 3.91% (-0.26%)

11% less funds holding

Funds holding: 65 → 58 (-7)

28% less capital invested

Capital invested by funds: $218M → $156M (-$61.9M)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
58
Holders Change
-7
Holders Change %
-10.77%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
22
Reduced
13
Closed
12
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$2.07M
2
APM
Avidity Partners Management
Texas
+$1.31M
3
6CM
683 Capital Management
New York
+$542K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$465K
5
State Street
State Street
Massachusetts
+$349K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$10.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.02M
3
VA
VR Adviser
New York
-$1.89M
4
Millennium Management
Millennium Management
New York
-$563K
5
Two Sigma Investments
Two Sigma Investments
New York
-$442K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$9K -$12.3K -99 -58%
PCM
52
Penserra Capital Management
California
$5K +$124 +1 +2%
Fifth Third Bancorp
53
Fifth Third Bancorp
Ohio
$1K – – –
UBS Group
54
UBS Group
Switzerland
$1K +$1.24K +10 New
CCM
55
Consonance Capital Management
New York
– -$10.6M -64,088 Closed
Adage Capital Partners
56
Adage Capital Partners
Massachusetts
– -$5.02M -30,500 Closed
VA
57
VR Adviser
New York
– -$1.89M -11,481 Closed
BCM
58
Bridgeway Capital Management
Texas
– -$206K -1,250 Closed
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
– -$201K -1,223 Closed
JF
60
Jump Financial
Illinois
– -$137K -831 Closed
Marshall Wace
61
Marshall Wace
United Kingdom
– -$129K -784 Closed
ProShare Advisors
62
ProShare Advisors
Maryland
– -$115K -696 Closed
Acadian Asset Management
63
Acadian Asset Management
Massachusetts
– -$50K -303 Closed
SO
64
STRS Ohio
Ohio
– -$49K -300 Closed
PHK
65
Point72 Hong Kong
Hong Kong
– -$18K -108 Closed
PAM
66
Panagora Asset Management
Massachusetts
– -$6K -34 Closed
EI
67
Ellevest Inc
New York
– +$124 +1 New
1 2
3

ACET Hedge Fund Activity: Q3 2021 in Review

58 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q3 2021, worth a combined $156M — down 28% from $218M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ACET and 6 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 22 added.

The largest buyer was Ikarian Capital, adding an estimated $2.07M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $10.6M sold.

  • 58 institutional investors held Adicet Bio (ACET) as of Q3 2021, down from 65 in Q2 2021.
  • Funds reported $156M of Adicet Bio stock for Q3 2021, down 28% quarter-over-quarter.
  • 6 funds opened new Adicet Bio positions in Q3 2021 and 12 closed out, a net change of -6 holders.
  • The largest Adicet Bio buyer in Q3 2021 was Ikarian Capital, an estimated $2.07M added.
  • The largest Adicet Bio seller in Q3 2021 was Consonance Capital Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2021.